Position in DSGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$181,848
-$57,688 QoQ
Shares Held
17,091
-33.1% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. DSGN ranks #331 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in DSGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $181,848 | 17,091 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $239,536 | 25,537 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $170,878 | 22,693 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $92,141 | 27,342 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $126,681 | 32,819 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $410,841 | 66,587 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $80,054 | 14,880 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,755 | 13,360 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $133,122 | 33,033 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $133,668 | 50,441 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $42,631 | 18,064 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $152,220 | 24,162 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,188 | 206 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,600,836 | 156,027 | Shares | Defined | 2023-02-08 | |
| 2022-03-31 | $16,117 | 998 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $749 | 35 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,658 | 1,134 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,905 | 498 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,970 | 300 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||